Mapping Institutional Identities and the Production of Ethics

NCT ID: NCT03983863

Last Updated: 2024-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

61 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-30

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

Researchers want to learn how members of IRB committees interact with each other. They want to see how this affects the decision-making process. They want to learn how members see their role and the roles of their fellow members. They want to see if these views are actualized during meetings. To do this, researchers will sit in on IRB meetings and interview committee members.

Objective:

To explore the dynamics between IRB members. To explore how these dynamics affect the IRB process of decision making.

Eligibility:

NIH IRB staff or members

Design:

In Phase I, an investigator (AI) will sit in on IRB meetings for 6 months. The AI will take notes on the dynamics of the committees. The AI s will focus will be on the dialogue and the behavior of both the group and each member. The AI will also focus on the factors that form the decision-making process. The AI will audio-record the meetings to help take detailed notes. These recordings will be destroyed after 3 months.

If the AI does not hear from members before the IRB meetings, the AI will assume that the member is agreeing to take part in Phase I.

In Phase II, the AI will contact some members about taking part in a 60-minute interview. The interview will be semi-structured. It will be on site and in person. It will explore how the members see their role and the roles of others on the committee.

Contact information will be collected only for members who take part in Phase II.

Data will be de-identified.

Withdrawing from the study will not affect any member s role on the IRB.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective: The study has two objectives. The primary objective is to explore what dynamics exist within IRB committees, how members in each role interact with each other, and how these interactions affect participation in the deliberation/decision-making process.

The secondary objective of this research is to explore what each member/staff perceives his/her role and the roles of other committee members to be and whether these perceptions are congruent with how roles are actualized during meetings.

Study Population: Our target population consists of all members/staff of NIH IRBs and IRB panels that fall under the NIH Intramural Federal Wide Assurance (FWA).

Design: The project will involve two phases: direct observation and semi-structured interviews. Phase I (direct-observations) will involve an associate investigator, Hina Walajahi, sitting in on regularly scheduled IRB meetings at the NIH and taking observational notes on committee dialogue, individual and group behavior, and factors that contribute to the decision-making process. Meetings will be audio-recorded in order to validate the observation notes. The observational data will be used to select appropriate committee members/staff and guide questions for the semi-structured interviews.

For Phase II (semi-structured interviews), the same associate investigator will conduct in-person, semi-structured interviews with contacted IRB members/staff regarding role perception respective to other members and the committee as a whole. Interviews will last approximately 60 minutes. They will be audio-recorded and transcribed.

Outcome Measures: A qualitative codebook will be created from observational and interview data, focusing on themes including, but not limited to: member interactions, member participation in discussion, committee deliberation processes and voting behavior.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

IRB Decision Making

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IRB

Our target study population consists of all members/staff of NIH IRBs and IRB panels that fall under the NIH Intramural Federal Wide Assurance (FWA).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ELIGIBILITY CRITERIA:

All members/staff of NIH IRBs and IRB panels that fall under the NIH Intramural Federal Wide Assurance (FWA).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Human Genome Research Institute (NHGRI)

NIH

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara C Hull, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

National Human Genome Research Institute (NHGRI)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Human Genome Research Institute (NHGRI)

Bethesda, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-HG-N106

Identifier Type: -

Identifier Source: secondary_id

999919106

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Personalized Genomic Research
NCT01294345 COMPLETED
Inherited Reproductive Disorders
NCT01500447 RECRUITING